FDA Inspection
Orient Pharma Co., Ltd. Yunlin PlantOrient Pharma Co., Ltd. Yunlin Plant – FDA Inspection, Jul 6, 2018
Record Details
This FDA Inspection record concerns Orient Pharma Co., Ltd. Yunlin Plant, with an inspection on July 6, 2018, issued by the Office of Inspections and Investigations, covering human drugs.
View Company Profile
ID · 67b73ca1-769c-4cc8-b767-a5b6b3ce38bb
Inspection Facts
- Inspection number
- 1062312
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Orient Pharma Co., Ltd. Yunlin Plant
4| Date | Classification | Office | Project area |
|---|---|---|---|
| May 23, 2025 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 16, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 3, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 14, 2012 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Orient Pharma Co., Ltd. Yunlin Plant
- FDA Inspection 1274326 - 2025-05-23
- FDA Inspection 1077757 - 2018-11-16
- FDA Inspection 921908 - 2015-04-03
- FDA Inspection 813081 - 2012-12-14
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.